<DOC>
	<DOCNO>NCT00462124</DOCNO>
	<brief_summary>Primary Goal The study 's primary goal ass safety BioProtect biodegradable balloon implant implantation procedure , prostate cancer subject undergoing routine XRT treatment . Safety BioProtect device assess report adverse event . Secondary Goal The study 's secondary goal evaluate effectiveness BioProtect biodegradable balloon implant prostate cancer subject undergoing routine XRT treatment . Effectiveness assess term increase distance anterior rectal wall prostate noticeable reduction isodose rectum .</brief_summary>
	<brief_title>Evaluation Safety Efficacy BioProtect Balloon Prostate Cancer Subjects Undergoing Radiotherapy</brief_title>
	<detailed_description>Primary Endpoint Parameters The safety endpoint incidence complication related BioProtect balloon implant implantation procedure : 1 . Serious Adverse Events related BioProtect balloon and/or implantation procedure . Serious adverse event define adverse requiring operation and/or associate prolongation hospital stay . Serious Adverse Events document Serious Adverse Event Form . 2 . Adverse Events related BioProtect balloon and/or implantation procedure . Adverse Events document Adverse Event Form . 3 . Subjective discomfort relate balloon implantation procedure assess pain analogue scale . Secondary Endpoint Parameters To assess efficacy BioProtect biodegradable balloon implant . Efficacy measure term : 1 . Increased distance anterior rectal wall prostate post implantation show CT last radiation treatment . 2 . Noticeable reduction isodose level rectum post implantation compare pre-implantation isodose rectum XRT treatment planning software . Other Measured Observations 1 . Balloon non-displacement treatment phase show CT. 2 . Balloon remain inflated treatment phase show CT. 3 . Operator satisfaction BioProtect balloon implantation procedure .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male age ≤80 . Men child produce potential ( sterile ) must accept use adequate contraceptive throughout radiotherapy phase least 3 month completion radiotherapy phase ever heterosexual intercourse . Diagnosed prostate cancer spread outside capsule ( T1 T2 ) . Subject schedule localized prostate XRT treatment . Zubrod performance status 01 ; Karnofsy &gt; 80 . Prerandomization serum PSA low 25 ( obtain prior LHRH antiandrogen therapy ) ; Kattan nomogram less 15 % . Subject able comprehend give inform consent participation study . Probability lymph node involvement base Kattan nomogram less 15 % . Normal blood CBC biochemistry two week screen follow : Normal CBC Absolute neutrophil count ( ANC ) ≥ 1,800 cells/mm3 Platelets ≥ 100,000 cells/mm3 Hemoglobin ≥ 10.0 g/dl Adequate renal function , serum creatinine ≤ 2.0 mg/dl Adequate liver function , serum bilirubin &lt; 2.0 mg/dl Adequate liver function SGOT/SGPT &lt; 2.5 x upper normal limit Normal value PT , PTT INR test . Signed Informed Consent Form . Prior radical prostatectomy , cryosurgery radiotherapy prostate cancer , local therapy prostate cancer . Prior radiotherapy pelvis , include brachytherapy body organ . Unstable angina and/or congestive heart failure require hospitalization within last 6 month prior screen . Transmural myocardial infarction within last 6 month prior screen . Acute infection require intravenous antibiotic time screen . Bleeding disorder . Uncontrolled diabetes mellitus HIV positive immunosuppressive disorder . Renal failure ( Serum creatinine &gt; 2.0 mg/dl ) . Inflammatory disease perineal skin . Urinary tract infection acute chronic prostatitis . Active inflammatory bowel disease . Rectal carcinoma . Subjects anterior resection rectum rectal amputation . Known cognitive disorder . Concurrent participation clinical study . Physician objection .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Prostate</keyword>
	<keyword>cancer</keyword>
	<keyword>radiation</keyword>
	<keyword>biodegradable implantable balloon</keyword>
	<keyword>intrarectal balloon</keyword>
</DOC>